Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02668666 |
Title | Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Oana Danciu, MD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Illinois Cancer Center | Chicago | Illinois | 60612 | United States | Details | |
Michigan State University | Lansing | Michigan | 48910 | United States | Details | |
University of Minnesota | Minneapolis | Minnesota | 55455 | United States | Details | |
University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
Penn State Cancer Institute | Hershey | Pennsylvania | 17033 | United States | Details | |
University of Wisconsin | Madison | Wisconsin | 53705 | United States | Details | |
ProHealth Care | Waukesha | Wisconsin | 53188 | United States | Details |